Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China
Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China
1 other identifier
interventional
80
1 country
1
Brief Summary
This study aims to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 3, 2009
CompletedFirst Posted
Study publicly available on registry
August 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFebruary 11, 2014
August 1, 2009
1.2 years
August 3, 2009
February 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
quality of life
three weeks and six weeks
Study Arms (2)
life review
EXPERIMENTALa life review program includes 3-session life review and formulation of a life review book as a gift for advanced cancer patients.
controlled group
NO INTERVENTIONthe subjects in the controlled group do not receive the life review program
Interventions
The life review program includes reviewing a life and formalating a life booklet. Reviewing a life consists of three weekly sessions separately addressing illness experience, adulthood life and childhood and adolescence life. Each session lasts about 30 to 60mintues.A booklet with photos documented significant life events will be produced as a gift for the subjects. The edition, photos and contents fo the booklet are determined by the subjects.
Eligibility Criteria
You may qualify if:
- Patients who are newly admitted to the study hospice
- Patients who are suffering from cancer with metastasis made by a physician
- Patients who know their diagnosis, prognosis and therapy
- Patients' functional performance (the score of KPS) at or more than 50%
- Patients who are adults (≥18 years old)
- Patients who have no cognitive and verbal communication impairments
You may not qualify if:
- Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
- Patients with psychiatric disorders
- Patients who live outside Fuzhou since the following-up home visit services are not extended to those areas
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Fujian Hospice
Fuzhou, Fujian, 350001, China
Study Officials
- PRINCIPAL INVESTIGATOR
Enid Kwong, PhD
School of Nursing, The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 3, 2009
First Posted
August 4, 2009
Study Start
February 1, 2009
Primary Completion
April 1, 2010
Study Completion
June 1, 2010
Last Updated
February 11, 2014
Record last verified: 2009-08